Kate Traynor. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Analgesics, Opioid/adverse effectsConstipation/drug therapyConstipation/etiologyDrug ApprovalHumansInjections, SubcutaneousNaltrexone/administration & dosageNaltrexone/adverse effectsNaltrexone/analogs & derivativesNaltrexone/therapeutic useNarcotic Antagonists/administration & dosageNarcotic Antagonists/adverse effectsNarcotic Antagonists/therapeutic usePalliative CareQuaternary Ammonium Compounds/administration & dosageQuaternary Ammonium Compounds/adverse effectsQuaternary Ammonium Compounds/therapeutic useReceptors, Opioid, mu/antagonists & inhibitorsUnited StatesUnited States Food and Drug Administration
Substances： See more » Analgesics, OpioidNarcotic AntagonistsQuaternary Ammonium CompoundsReceptors, Opioid, mumethylnaltrexoneNaltrexone
Year: 2008 PMID： 18499867 DOI： 10.2146/news080043
Source DB: PubMed Journal: Am J Health Syst Pharm ISSN： 1079-2082 Impact factor: 2.637